Browse News Stories
21 to 30 of 1,022 stories
view headlines only
-
Personalizing Prostate Specific Antigen Testing May Improve Specificity, Reduce Biopsies
April 15, 2013 Genetic variants have been identified which can increase serum prostate specific antigen (PSA) concentrations and prostate cancer risk. A new study reports that correcting PSA levels for these ... > full story -
Small Molecule Unlocks Key Prostate Cancer Survival Tactic
April 9, 2013 The most recent in a series of studies has shown that a single molecule is at the heart of one of the most basic survival tactics of prostate cancer ... > full story -
First Genetic Factor in Prostate Cancer Prognosis Identified
April 9, 2013 Patients with prostate cancer and hereditary mutations in the BRCA2 gene have a worse prognosis and lower survival rates than do the rest of the patients with the ... > full story -
New Prostate Cancer Screening Guidance Statement
April 8, 2013 Men between the ages of 50 and 69 should discuss the limited benefits and substantial harms of the prostate-specific antigen test with their doctor before undergoing screening for prostate cancer, ... > full story -
Avian Virus May Be Harmful to Cancer Cells
April 8, 2013 Researchers have discovered that a genetically engineered Newcastle disease virus, which harms chickens but not humans, kills prostate cancer cells of all kinds, including hormone-resistant cancer ... > full story -
Counting Copy Numbers Characterizes Prostate Cancer
April 5, 2013 Non-invasive ‘liquid biopsies’ can find metastatic or recurrent prostate cancer, in a low cost assay suitable for most healthcare systems, finds new research. Genomic signatures of ... > full story -
Prostate Cancer Treatment Study Changing the Way Doctors Practice
April 4, 2013 A new article recommends a dramatic shift in treating metastatic prostate cancer. Hormone therapy has been shown to extend the lives of patients, but it causes unpleasant side effects in men like ... > full story -
On-and-Off Approach to Prostate Cancer Treatment May Compromise Survival
April 3, 2013 Taking a break from hormone-blocking prostate cancer treatments once the cancer seems to be stabilized is not equivalent to continuing therapy, a new large-scale international study ... > full story -
Landmark Study Describes Prostate Cancer Metastasis Switch
April 2, 2013 SPDEF acts as a switch, regulating production of E-Cadherin, the loss of which is a prerequisite of metastasis in many ... > full story -
Newly Identified Tumor Suppressor Provides Therapeutic Target for Prostate Cancer
April 1, 2013 Researchers have found that the enzyme PKCzeta controls the activation of a pro-tumor gene called c-Myc. Normally, PKCzeta's alteration keeps c-Myc in check. But PKCzeta levels are low in prostate ... > full story
Search ScienceDaily
Number of stories in archives: 138,557

